Drug Entity definition
Drug Entity means the generic version of a molecular compound of which one or more dosage forms or strengths are approved for prescription use by the U.S. Food and Drug Administration, and for which at least one available form or strength is listed on the MAC list for the Selected State or the FUL list. In choosing the three Drug Entities, the IRO shall request that Walgreens identify any Drug Entity that Walgreens stocks in its warehouses or distribution centers and for which Walgreens’s acquisition costs or purchase volumes have changed significantly during the Reporting Period. The IRO will also review any new contracts related to the purchase of Drug Entities entered into by Walgreens and any Drug Entities that were the subject of any Therapeutic Interchange Program(s) during the Reporting Period, prior versions of such contracts, and correspondence related to the negotiation of the new contracts. Based on its review of this information, the IRO shall select the three Drug Entities to be reviewed. The IRO shall not at any time communicate to OIG any information that identifies Walgreens’ acquisition costs of particular prescription medications or other confidential proprietary information of Walgreens. Within 30 days after OIG receives the IRO’s recommendation, OIG shall notify the IRO if its recommendation is acceptable. If OIG determines that the IRO’s recommendations are acceptable, the drugs recommended by the IRO shall be reviewed in accordance with this Section III.D. Absent notification from OIG that the IRO’s recommendations are unacceptable, the IRO shall review the recommended drugs. Each drug selected pursuant to this process for each Reporting Period shall be referred to herein as a “Selected Drug.”
Examples of Drug Entity in a sentence
In choosing the three Drug Entities, the IRO shall request that Walgreens identify any Drug Entity that Walgreens stocks in its warehouses or distribution centers and for which Walgreens’s acquisition costs or purchase volumes have changed significantly during the Reporting Period.